chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, COVID-19 immunisation, Hypertension, Interchange of vaccine products
Clinical narrative: patient had high blood pressure; had COVID very bad, a lot has happened; person receives Moderna as a 1st vaccine and as a 2nd vaccine dose another brand of COVID19 vaccine,; person receives Moderna as a 1st vaccine and as a 2nd vaccine dose another brand of COVID19 vaccine,; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (patient had high blood pressure), COVID-19 (had COVID very bad, a lot has happened), INTERCHANGE OF VACCINE PRODUCTS (person receives Moderna as a 1st vaccine and as a 2nd vaccine dose another brand of COVID19 vaccine,) and COVID-19 IMMUNISATION (person receives Moderna as a 1st vaccine and as a 2nd vaccine dose another brand of COVID19 vaccine,) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. ASKU) for COVID-19 prophylaxis.    Co-suspect product included non-company product COVID-19 VACCINE for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and second dose of COVID-19 VACCINE (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERTENSION (patient had high blood pressure), COVID-19 (had COVID very bad, a lot has happened), INTERCHANGE OF VACCINE PRODUCTS (person receives Moderna as a 1st vaccine and as a 2nd vaccine dose another brand of COVID19 vaccine,) and COVID-19 IMMUNISATION (person receives Moderna as a 1st vaccine and as a 2nd vaccine dose another brand of COVID19 vaccine,). At the time of the report, HYPERTENSION (patient had high blood pressure), COVID-19 (had COVID very bad, a lot has happened), INTERCHANGE OF VACCINE PRODUCTS (person receives Moderna as a 1st vaccine and as a 2nd vaccine dose another brand of COVID19 vaccine,) and COVID-19 IMMUNISATION (person receives Moderna as a 1st vaccine and as a 2nd vaccine dose another brand of COVID19 vaccine,) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication list was not provided. The reporter stated that the patient had COVID very bad, a lot has happened and patient had to be resuscitated and all of this happened after receiving the vaccine. Reporter was hospitalized and someone told them that patient received another brand of COVID19 vaccine as a second dose while looking through patients immunization records. Reporter stated that the patient had high blood pressure and that patient was at risk. Reporter wanted to know if was normal to receive another brand of COVID19 vaccine as a second dose. Treatment medication information was not provided.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: She began experiencing symptoms of Covid Omicron virus 30Dec2021 and did a home test 01Jan2022; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (She began experiencing symptoms of Covid Omicron virus 30Dec2021 and did a home test 01Jan2022) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   On 10-Aug-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Dec-2021, the patient experienced COVID-19 (She began experiencing symptoms of Covid Omicron virus 30Dec2021 and did a home test 01Jan2022). At the time of the report, COVID-19 (She began experiencing symptoms of Covid Omicron virus 30Dec2021 and did a home test 01Jan2022) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Jan-2022, SARS-CoV-2 test: She began experiencing symptoms of Covid Omicron virus 30Dec2021 and did a home test 01Jan2022. On an unknown date, COVID-19: Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product reported by the reporter. It was unknown that the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Patient stated that she received all Moderna vaccines, the Primary series and initial booster. She began experiencing symptoms of Covid Omicron virus 30Dec2021 and did a home test 01-Jan-2022. No AE filed at the time because the patient stated that she was part of Moderna vaccine clinical trial study and  at the time that she contracted the virus and reported it to them. They performed a second test which was positive. The study has since ended and she received the last booster 10-Aug-2022 as well as the flu shot. No treatment medication reported by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Accidental underdose, No adverse event
Clinical narrative: No adverse event; bivalent was given in the 0.3 ml instead of the 0.5 ml to a patient today 28Dec2022; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (bivalent was given in the 0.3 ml instead of the 0.5 ml to a patient today 28Dec2022) and NO ADVERSE EVENT (No adverse event) in an adult male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 053D22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 28-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .3 milliliter. On 28-Dec-2022,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced ACCIDENTAL UNDERDOSE (bivalent was given in the 0.3 ml instead of the 0.5 ml to a patient today 28Dec2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (bivalent was given in the 0.3 ml instead of the 0.5 ml to a patient today 28Dec2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        The action taken with mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown) was unknown.   For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (bivalent was given in the 0.3 ml instead of the 0.5 ml to a patient today 28Dec2022).    No concomitant medications details were reported.  It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Moderna was not authorized to communicate with the patient's primary healthcare professional regarding this notification. The nurse stated their facility provides Moderna vaccines. The nurse declined to provide further patient information.  No treatment medications details were reported.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Wrong product administered
Clinical narrative: no adverse event; patient was supposed to take the 2nd primary shot, but received Bivalent booster on 27DEC2022 (Lot# AS7168B MFG Expiration Date: 08Jun2023 ).; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (patient was supposed to take the 2nd primary shot, but received Bivalent booster on 27DEC2022 (Lot# AS7168B MFG Expiration Date: 08Jun2023 ).) and NO ADVERSE EVENT (no adverse event) in a 55-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7168B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 27-Dec-2022, the patient received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 27-Dec-2022,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced WRONG PRODUCT ADMINISTERED (patient was supposed to take the 2nd primary shot, but received Bivalent booster on 27DEC2022 (Lot# AS7168B MFG Expiration Date: 08Jun2023 ).). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (patient was supposed to take the 2nd primary shot, but received Bivalent booster on 27DEC2022 (Lot# AS7168B MFG Expiration Date: 08Jun2023 ).) outcome was unknown and NO ADVERSE EVENT (no adverse event) had not resolved.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (patient was supposed to take the 2nd primary shot, but received Bivalent booster on 27DEC2022 (Lot# AS7168B MFG Expiration Date: 08Jun2023 ).).    Concomitant product use was not provided by the reporter.  Treatment information was not provided.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Anaemia, Blood test, Fatigue, Immunisation reaction, Mean cell haemoglobin
Clinical narrative: anemic; lost 20 pounds; low grade fever 99.5 to 100 highest; fatigue; delayed reaction; This spontaneous case was reported by a patient and describes the occurrence of ANAEMIA (anemic), WEIGHT DECREASED (lost 20 pounds), IMMUNISATION REACTION (delayed reaction), PYREXIA (low grade fever 99.5 to 100 highest) and FATIGUE (fatigue) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 051C21A and 031B21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In August 2021, the patient experienced IMMUNISATION REACTION (delayed reaction). On an unknown date, the patient experienced ANAEMIA (anemic), WEIGHT DECREASED (lost 20 pounds), PYREXIA (low grade fever 99.5 to 100 highest) and FATIGUE (fatigue). At the time of the report, ANAEMIA (anemic), PYREXIA (low grade fever 99.5 to 100 highest) and FATIGUE (fatigue) had resolved and WEIGHT DECREASED (lost 20 pounds) and IMMUNISATION REACTION (delayed reaction) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Sep-2021, Blood test: narrowed down their anemia to low ferritin. On 21-Feb-2022, Serum ferritin: back in normal range at 88, Next reading was 120 in Jun2022. On 18-Oct-2022, Serum ferritin: came back into full normal range for 204. On an unknown date, Mean cell haemoglobin: size of red blood size typical run high end of normal but came down to the mid range of normal. On an unknown date, Mean cell volume: size of red blood size typical run high end of normal but came down to the mid range of normal. On an unknown date, Serum ferritin: ferritin which should have been in 200 range was 11 and completely eliminated. On an unknown date, Weight: lost 20 pounds.         No concomitant medication was received.  The patient also lost 20 pounds with no lifestyle changes whatsoever but had not gained weight back.  The patient recommended they took an iron supplement and the ferritin went from 14 to 11 so they stopped taking it and let it resolve on its own.
Sex: M
Vaccine: COVID19
Symptoms: Mean cell volume, Pyrexia, Serum ferritin, Weight, Weight decreased
Clinical narrative: anemic; lost 20 pounds; low grade fever 99.5 to 100 highest; fatigue; delayed reaction; This spontaneous case was reported by a patient and describes the occurrence of ANAEMIA (anemic), WEIGHT DECREASED (lost 20 pounds), IMMUNISATION REACTION (delayed reaction), PYREXIA (low grade fever 99.5 to 100 highest) and FATIGUE (fatigue) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 051C21A and 031B21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In August 2021, the patient experienced IMMUNISATION REACTION (delayed reaction). On an unknown date, the patient experienced ANAEMIA (anemic), WEIGHT DECREASED (lost 20 pounds), PYREXIA (low grade fever 99.5 to 100 highest) and FATIGUE (fatigue). At the time of the report, ANAEMIA (anemic), PYREXIA (low grade fever 99.5 to 100 highest) and FATIGUE (fatigue) had resolved and WEIGHT DECREASED (lost 20 pounds) and IMMUNISATION REACTION (delayed reaction) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Sep-2021, Blood test: narrowed down their anemia to low ferritin. On 21-Feb-2022, Serum ferritin: back in normal range at 88, Next reading was 120 in Jun2022. On 18-Oct-2022, Serum ferritin: came back into full normal range for 204. On an unknown date, Mean cell haemoglobin: size of red blood size typical run high end of normal but came down to the mid range of normal. On an unknown date, Mean cell volume: size of red blood size typical run high end of normal but came down to the mid range of normal. On an unknown date, Serum ferritin: ferritin which should have been in 200 range was 11 and completely eliminated. On an unknown date, Weight: lost 20 pounds.         No concomitant medication was received.  The patient also lost 20 pounds with no lifestyle changes whatsoever but had not gained weight back.  The patient recommended they took an iron supplement and the ferritin went from 14 to 11 so they stopped taking it and let it resolve on its own.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: COVID after COVID Vaccines; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (COVID after COVID Vaccines) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0770218) for COVID-19 prophylaxis.    Co-suspect product included non-company product COVID-19 VACCINE NRVV AD26 (JNJ 78436735) (JANSSEN COVID-19 VACCINE) for an unknown indication.    The patient's past medical history included Knee replacement. Concurrent medical conditions included Seizures since 1999, Asthma (The patient had this condition for probably a year or a little longer.), COPD (The patient was not sure how long she had this condition, but she knew she had not had it as long as she had the asthma.), Dust allergy, Pollen allergy, Allergy to animal (Allergic to dogs, cats and things like that.), Restless legs, Arthritis, Heartburn and Blood pressure abnormal. Concomitant products included FLUTICASONE PROPIONATE and AZELASTINE for Allergy, MELOXICAM for Arthritis, SALBUTAMOL SULFATE (PROAIR RESPICLICK) and BENRALIZUMAB (FASENRA) for Asthma, BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) for Asthma and COPD, VERAPAMIL for Blood pressure abnormal, ESOMEPRAZOLE MAGNESIUM for Heartburn, ROPINIROLE HCL for Restless legs, TOPIRAMATE (TROKENDI XR) for Seizures.   On 27-Mar-2021, the patient received first dose of COVID-19 VACCINE NRVV AD26 (JNJ 78436735) (JANSSEN COVID-19 VACCINE) (unknown route) 1 dosage form. On 10-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Nov-2022, the patient experienced COVID-19 (COVID after COVID Vaccines). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) in November 2022 for COVID-19, at an unspecified dose and frequency. At the time of the report, COVID-19 (COVID after COVID Vaccines) outcome was unknown.            Ethnicity of the patient was reported.  The patient stated that she had lot of allergies, she also got unspecified allergy shots at the doctor twice a week.  The patient had to take Paxlovid because she was sick from having COVID. The patient reported that the Paxlovid was dispensed to her on 07-Nov-2022. The patient had brain fog in November with Paxlovid. She mentioned that she could not concentrate long enough, it was difficult to do anything. The patient also mentioned that at the time she was on Paxlovid, it was the only medication that she had a reaction to. The patient also took Aspirin 81 mg once a day and stated she thought she started this medication at the last time when she saw her doctor, on 12-Dec-2022. The patient reported that Paxlovid had been listed as an allergy for her. NDC number of Paxlovid was reported as 00069-1085-30. The patient did not have any laboratory testing related to the event.   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2022: Upon follow-up, QE ID (product quality complaint number) was added.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccination site pain
Clinical narrative: He had only a sore arm after each shot; After 2nd vaccine he had COVID Disease in JUN2022; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (He had only a sore arm after each shot) and COVID-19 (After 2nd vaccine he had COVID Disease in JUN2022) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A, 025B21A, 033F21A and 048L21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Mar-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In June 2022, the patient experienced COVID-19 (After 2nd vaccine he had COVID Disease in JUN2022). On an unknown date, the patient experienced VACCINATION SITE PAIN (He had only a sore arm after each shot). At the time of the report, VACCINATION SITE PAIN (He had only a sore arm after each shot) and COVID-19 (After 2nd vaccine he had COVID Disease in JUN2022) had resolved.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  The patient was calling to report that he received 5 Moderna COVID-19 shots. After second vaccine he had COVID Disease in Jun-2022.  Shot one was first Primary Monovalent Dose. Shot two was second Primary Monovalent Dose. Shot three was first Monovalent Booster Dose. Shot four was second Monovalent Booster Dose. Shot five was Bivalent Booster.  The patient had only a sore arm after each shot.  Treatment information was not provided.   This case was linked to MOD-2022-692728 (Patient Link).
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Pain, Product dose omission issue
Clinical narrative: Patient had terrible side effects, he has aches and pains (like the flu); Patient had terrible side effects, he has aches and pains (like the flu); He did not take the second dose of Moderna; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Patient had terrible side effects, he has aches and pains (like the flu)), PAIN (Patient had terrible side effects, he has aches and pains (like the flu)) and PRODUCT DOSE OMISSION ISSUE (He did not take the second dose of Moderna) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    In 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Patient had terrible side effects, he has aches and pains (like the flu)), PAIN (Patient had terrible side effects, he has aches and pains (like the flu)) and PRODUCT DOSE OMISSION ISSUE (He did not take the second dose of Moderna). At the time of the report, INFLUENZA LIKE ILLNESS (Patient had terrible side effects, he has aches and pains (like the flu)), PAIN (Patient had terrible side effects, he has aches and pains (like the flu)) and PRODUCT DOSE OMISSION ISSUE (He did not take the second dose of Moderna) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was withdrawn on an unknown date.       Concomitant medication information was not provided.  On 09-Dec-2022, it was reported that a patient started treatment on an unspecified date in 2020 with Moderna Covid-19 vaccine. It was reported the patient had terrible side effects, he had aches and pains (like the flu), and was calling out for his deceased father in his sleep, and he did not take the second dose of Moderna.  Treatment information was not provided.
Age: 77.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse Event; Patient got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse Event) in a 77-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 26-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 26-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse Event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse Event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD).    No concomitant medication details was reported. No treatment medication details was reported.
Age: 67.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; Patient got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) in a 67-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 19-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 19-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD).    Patient registry ID was reported as 6561778  No concomitant medications were reported.  It was reported that, the patient received vaccine after the beyond use-by date.  No treatment medications were reported.
Age: 70.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse Event; patient got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse Event) in a 70-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 26-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 26-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse Event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse Event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (patient got vaccinated after BUD).    No relevant concomitant medications were reported.  No treatment information was provided.
Age: 68.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) in a 68-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 19-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 19-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD).    No concomitant medications were reported.  It was reported that, the patient received vaccine after the beyond use-by date.  No treatment medications were reported.
Age: 78.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; Patient that got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient that got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) in a 78-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 26-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 26-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient that got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient that got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient that got vaccinated after BUD).    Patient registry ID was reported.  No concomitant medication information was reported. No treatment information was provided.
Age: 76.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse Event; Patient got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse Event) in a 76-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 26-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 26-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse Event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse Event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD).    Patient registry ID was reported.  No concomitant medications were reported.  It was reported that, the patient received vaccine after the beyond use-by date.  No treatment medications were reported.
Age: 82.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse Event; got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse Event) in an 82-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 26-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 26-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse Event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse Event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD).    No concomitant medications were reported.  It was reported that, the patient received vaccine after the beyond use-by date.  No treatment medications were reported.
Age: 83.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse reaction; Got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Got vaccinated after BUD) and NO ADVERSE EVENT (No adverse reaction) in an 83-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 03-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse reaction). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Got vaccinated after BUD) and NO ADVERSE EVENT (No adverse reaction) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse reaction) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Got vaccinated after BUD).    No concomitant medications were reported.  It was reported that, the patient received vaccine after the beyond use-by date.  No treatment medications were reported.
Age: 59.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) in a 59-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 03-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD).    No concomitant drug was reported. No treatment drug was reported.
Age: 57.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; Patient got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) in a 57-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 03-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD).    No concomitant medications were reported.  It was reported that, the patient received vaccine after the beyond use-by date.  No treatment medications were reported.
Age: 91.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; patient got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) in a 91-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 26-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 26-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (patient got vaccinated after BUD).    No relevant concomitant medications were reported.  No treatment information was provided.
Age: 27.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse reaction; got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse reaction) in a 27-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 03-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse reaction). At the time of the report, EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse reaction) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse reaction) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD).    No concomitant medications were reported.  It was reported that, the patient received vaccine after the beyond use-by date.  No treatment medications were reported.
Age: 57.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) in a 57-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 03-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD).    No concomitant medication were reported. No treatment information was provided by the reporter.The patient got vaccinated after BUD.
Age: 60.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; Patient got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) in a 60-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 03-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD).    No concomitant medications were reported. It was reported that, the patient received vaccine after the beyond use-by date. No treatment medications were reported.
Age: 73.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse reaction; Got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Got vaccinated after BUD) and NO ADVERSE EVENT (No adverse reaction) in a 73-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 19-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 19-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse reaction). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Got vaccinated after BUD) and NO ADVERSE EVENT (No adverse reaction) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse reaction) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Got vaccinated after BUD).    No concomitant medications were reported.  It was reported that, the patient received vaccine after the beyond use-by date.  No treatment medications were reported.
Age: 73.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) in a 73-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 03-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD).    Patient registry ID was reported as Unknown.  No concomitant medications were reported.  It was reported that, the patient received vaccine after the beyond use-by date.  No treatment medications were reported.
Age: 78.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; Patient got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) in a 78-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 03-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) outcome was unknown.     For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD).    Patient registry ID was reported.  No concomitant medication information was provided.  It was reported that, the patient received vaccine after the beyond use-by date.  No treatment medication was provided.
Age: 73.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse Event; Patient got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse Event) in a 73-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 19-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 19-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse Event) outcome was unknown.      For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse Event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD).    Patient registry ID was reported as Unknown.  No concomitant medications were reported.  It was reported that, the patient received vaccine after the beyond use-by date.  No treatment medications were reported.
Age: 67.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse Event; patient got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse Event) in a 67-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 19-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 19-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse Event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse Event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (patient got vaccinated after BUD).    No relevant concomitant medications were reported.  No treatment information was provided.